☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CGRP Receptor Antagonist
Allergan Announces Completion of UBR-MD-04 & 3110-105-002 Study for Treatment of Migrane
October 18, 2018
Load more...
Back to Home